GYRE THERAPEUTICS, INC. (GYRE)
Pharmaceutical Preparations
Latest Price
$6.69
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
1.12
P/B Ratio
5.95
Valuation metrics
adjust assumptions →EPS: $0.02
Book value / share: $1.16
Formula: √(22.5 × EPS × BVPS)
Graham Number
$0.72
89% downside
EPS: $0.02
Target P/E: 15×
Formula: EPS × P/E
P/E Fair Value
$0.30
96% downside
Institutional Ownership
8.3% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| HSG Holding Ltd | 3.75M | $24.0M | 3.54% | -- | 2026-06-30 |
| BlackRock, Inc. | 993.9K | $6.0M | 0.94% | +235.3K | 2026-06-30 |
| Octagon Capital Advisors LP | 954.4K | $6.0M | 0.90% | -- | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 876.9K | $5.0M | 0.83% | -107.3K | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 533.0K | $3.0M | 0.50% | +101.5K | 2026-06-30 |
| STATE STREET CORP | 245.4K | $1.0M | 0.23% | +29.1K | 2026-06-30 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 184.3K | $1.0M | 0.17% | +19.0K | 2026-06-30 |
| Sixth Street Partners Management Company, L.P. | 184.3K | $1.0M | 0.17% | -- | 2026-06-30 |
| NORTHERN TRUST CORP | 169.5K | $1.0M | 0.16% | +35.7K | 2026-06-30 |
| SBI Securities Co., Ltd. | 166.8K | $1.0M | 0.16% | -4.1K | 2026-06-30 |